As leading pharmaceutical and cosmetic manufacturers in Korea, Kolmar’s facilities operate under global standards. Our plants are fully equipped with modern systems, advanced production lines, and rigorous quality control and inspection processes.

General Information

Osong Chungcheongbuk-Do Factory

The Osong plant is Korea’s leading pharmaceutical facility, specializing in high-quality oral tablets and oncology injectables.

Key Features
  • Compliant with cGMP and EU-GMP standards
  • Strict quality management system
  • Advanced infrastructure (facilities & IT systems)
  • Outstanding technology and over 30 years of experience

Osong IV Cheongju-Si, Chungcheongbuk-Do Factory

As one of the largest smart factories in Korea equipped with the latest automated facilities, the Osong Plant produces some of the highest quality IV products.

Key Features
  • One of the largest manufacturing facilities in Korea, equipped with the latest automated systems.
  • Smart factory operating on Big Data analysis and forecasting
  • An eco-friendly manufacturing facility utilizing renewable energy sources such as solar power
  • A global quality management system implemented to ensure the highest product quality

Daeso Eumseong-Gun Factory, Chungcheongbuk-Do

Daeso Plant manufactures infusion solutions, cephalosporin (Cepha) antibiotic FPP & API, and general API for both domestic and global supplies.

Key Features
  • Over 20 years of CMO partnership with major Japanese corporations.
  • Specialized technology for IV fluid manufacturing and automated facilities compliant with GMP standards
  • Dedicated manufacturing facility exclusively for K-CAB tablets API, Tegoprazan
  • 20 years of experience in sterile antibiotic manufacturing

Incheon Icheon-Si Factory, Gyeonggi-Do

With over 30 years of experience in biopharmaceutical manufacturing, the plant supplies its products to both domestic and international customers.

Key Features
  • Vaccine manufacturing facility compliant with GMP standards
  • With over 20 products registered in multiple countries, including Singapore and Thailand
  • A quality management system to ensure the production of high-quality products
  • Manufacturing technology and hands-on experience spanning over 30 years in the industry

Hanam Hanam-Si Factory, Gyeonggi-Do

With the establishment of a highly reliable GMP Cell Center, HK inno.N has been leading the industry in developing and manufacturing advanced biopharmaceutical products.

Key Features
  • One of Korea's largest automated manufacturing facilities featuring an enclosed system
  • GMP-compliant Cell & Gene Therapy manufacturing facility
  • A top-tier quality management system to ensure the production of high-quality products
  • Infrastructure for developing and optimizing CGT processes
Detail information

Address

239, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, South Korea

Manufacturing Facilities

Oral dosage formulation, Oncology injectables, Automated warehousing system, Quality Control & Quality Assurance (QC/QA) Building

Area

146.013 m²

Core Dosage Forms

Oral dosage formulation, oncology injectables

Building Area

58.896 m²

Certificate

OSHA-MS, ISO 45001, KGMP

Address

239, Osong Saengmyeong 2 Ro, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do, Korea

Manufacturing Facilities

IV manufacturing facility production lines, automated warehouse, and plant utilities.

Area

146.013 m²

Core Dosage Forms

Oral solid dosages, Oncology injectables, and IV fluids

Building Area

32.191 m²

Certificate

OSHA-MS

Address

20 Daeso Sandan-Ro, Daeso-Myeon, Eumseong-Gun, Chungcheongbuk-Do, Korea

Manufacturing Facilities

23 buildings including dedicated facilities for IV solutions, Tegoprazan, cephalosporin antibiotics, and TPN.

Area

57.278 m²

Core Dosage Forms

IV solutions, oral solid dosage products, cephalosporin API, and synthetic API

Building Area

28.313 m²

Certificate

KOSHA-MS, ISO 14001, KGMP, PMDA, Iran FDA

Address

Deokpyeong-ro, Deokpyeong-ri, Majang-myeon, Icheon-si, Gyeonggi-do, Korea

Manufacturing Facilities

10 buildings including dedicated facilities for vaccine production, Epokine, and quality management

Area

31.751 m²

Core Dosage Forms

Biopharmaceuticals (e.g., vaccines and recombinant proteins), and antibiotic injections

Building Area

14.491 m²

Certificate

KOSHA-MS, KGMP TFDA, NADFC, Philippines FDA

Address

Tòa nhà D, 947 Hanamdaero, Hanam-Si, Gyeonggi-Do, Korea

Manufacturing Facilities

Process development laboratory, analytical and quality control laboratory, sterile manufacturing room, and storage room

Area

1506 m²

Core Dosage Forms

Advanced biopharmaceuticals (for cell & gene therapy)

Building Area

1508 m²

Certificate

© Copyright © 2025 Hankol Healthcare Vina Co., Ltd - Website by Comma